LOMOOTHER 40mg capsules medication leaflet

L01AD02 lomustine • Antineoplastic and immunomodulating agents | Alkylating agents | Nitrosoureas

Lomustine is a chemotherapy medication used to treat certain types of cancer, including brain tumors, Hodgkin's lymphoma, and other advanced cancers. It belongs to the class of alkylating agents and works by damaging the DNA of cancer cells, preventing them from multiplying.

The medication is taken orally, usually in capsule form, and the dosage is adjusted based on body weight and the type of cancer being treated. Treatment is carried out under the strict supervision of an oncologist.

Side effects may include nausea, vomiting, decreased blood cell counts, fatigue, and an increased risk of infections. It is important for patients to be regularly monitored to assess the effectiveness of the treatment and manage any adverse reactions.

Pregnant or breastfeeding women should not use lomustine, and patients must inform their doctor about any other medications or supplements they are taking.

General data about LOMOOTHER 40mg

Substance: lomustine

Date of last drug list: 01-06-2025

Commercial code: W71021001

Concentration: 40mg

Pharmaceutical form: capsules

Quantity: 6

Product type: generic

Price: 790.25 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: THERDOSE PHARMA PVT. LTD. - INDIA

Holder: PHARMA S.A. - ROMANIA

Number: 1048/2025/01

Shelf life: 2 years

Pharmaceutical forms available for lomustine

Other substances similar to lomustine

Compensation lists for LOMOOTHER 40mg PHARMA

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

790.25 RON

790.25 RON

0.00 RON